1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. JOHNSON & JOHNSON
213.65 3.93 (1.87%)
11.4M
XNYS Volume

XNYS 13 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Payout Reduction
Delaware court partially cuts J&J’s $1 bn payout to Auris, easing potential damages by ~$200 mn See details

Johnson & Johnson - JNJ - stock price prediction, stock price target, analyst ratings from 25 analysts

Johnson & Johnson has a share price target of US$ 212, revenue growth forecast of 5.6%, and profit growth estimate of 73.2% for FY25, based on top 25 analyst calls.